Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

about

Use of Cannabinoids for Spasticity and Pain Management in MS.Cannabis Therapeutics and the Future of Neurology Traditional Uses of Cannabinoids and New Perspectives in the Treatment of Multiple Sclerosis

P2860

Q46968189-9B96DD2A-A6F5-452E-8BA6-B3EF0958E1A3 Q58596177-20A81836-7A81-4F8F-9A01-586CCEB5CA86 Q58775742-7A1E50D8-7270-4FC0-9A93-ADCAD259AE2C

P2860

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

Item

http://www.wikidata.org/entity/Q38580081

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

@en

type

Item

label

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

@en

prefLabel

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

@en

P1476

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

@en

P2093

Constantine Moschonas

http://www.w3.org/2001/XMLSchema#string

Heidi Moawad

http://www.w3.org/2001/XMLSchema#string

Katie Shepard

http://www.w3.org/2001/XMLSchema#string

Nancy Hammond

http://www.w3.org/2001/XMLSchema#string

Terry D Fife

http://www.w3.org/2001/XMLSchema#string

P2860

Marijuana: current concepts(†)

An evidence based review of acute and long-term effects of cannabis use on executive cognitive functions

Is cannabis neurotoxic for the healthy brain? A meta-analytical review of structural brain alterations in non-psychotic users

How many drug targets are there?

Effects of cannabis on cognition in patients with MS: a psychometric and MRI study.

Blurred boundaries: the therapeutics and politics of medical marijuana.

Clinical decisions. Medicinal use of marijuana--polling results.

Systematic review: efficacy and safety of medical marijuana in selected neurologic disorders: report of the Guideline Development Subcommittee of the American Academy of Neurology.

Is cannabis a gateway drug? Testing hypotheses about the relationship between cannabis use and the use of other illicit drugs.

Association of Cannabis Use during Adolescence, Prefrontal CB1 Receptor Signaling, and Schizophrenia

P304

344-351

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1212/CPJ.0000000000000162

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-08-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

26336632

http://www.w3.org/2001/XMLSchema#string

P921

medical cannabis

P932

4549715

http://www.w3.org/2001/XMLSchema#string

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

about

P2860

P2860

Clinical perspectives on medical marijuana (cannabis) for neurologic disorders.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P433

P478

P577

P698

P921

P932